"ARC Clinical Research William Cannon is a medical research clinic designated for clinical research projects."

During the past decade, ARC Clinical Research at William Cannon conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ARC Clinical Research at William Cannon" #1 sponsor was "Exact Sciences Corporation" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Cognoa, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "ModernaTX, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "ARC Clinical Research at William Cannon" are "COVID-19" (2 trials), "Colorectal Cancer" (2 trials), "Autism Spectrum Disorder" (1 trials), "Cytomegalovirus Infection" (1 trials) and "Migraine" (1 trials). Many other conditions were trialed in "ARC Clinical Research at William Cannon" in a lesser frequency.

Most popular intervention types in "ARC Clinical Research at William Cannon" are "Drug" (3 trials), "Diagnostic Test" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials), "Blood Sample Collection" (1 trials) and "Cognoa ASD diagnostic device" (1 trials). Other intervention names were less common.

The vast majority of trials in "ARC Clinical Research at William Cannon" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "ARC Clinical Research at William Cannon". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ARC Clinical Research at William Cannon, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ARC Clinical Research at William Cannon, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".